We proudly celebrate our 23rd birthday, celebrating innovation, collaboration and scientific excellence that Pharmidex has helped create!
May 19, 2025
Since 2002,
Pharmidex has grown into a trusted partner in preclinical drug discovery and development, contributing to over 16,000 studies across therapeutic areas including CNS, immunology, oncology, respiratory and stroke.
We’re proud to be AAALAC- and MHRA-accredited, providing high-quality GLP and GCP-compliant services that have supported clients across biotech, pharma, and academia worldwide.
Our integrated expertise in Clinical Pathology, DMPK, ADMET, Pharmacokinetics, Toxicology and BBB penetration studies continues to shape the success of early-stage drug candidates.
💡 As we commemorate this milestone, we reflect on:
✔ The dedication of our exceptional team
✔ The trust and collaboration of our partners and clients
✔ Our continued mission to advance science and improve lives
Here’s to 23 years of impact and many more to come!
#Pharmidex23 #DrugDiscovery #PharmaceuticalInnovation #CRO #DMPK #OncologyResearch #CNS #PreclinicalResearch #TeamPharmidex
Please join us in congratulating and welcoming: 👩🔬 Ella Ford – Pharmacology Student at the University of Bath 🧪 Tehleel Tahi r – Biochemistry Student at the University of Birmingham Both Ella and Tehleel will be gaining hands-on experience with our team, contributing to the innovative science and research we’re passionate about here at Pharmidex . We look forward to supporting their growth and development during their placement year and are delighted to have them on board!
Pharmidex is looking for a Bioanalytical Scientist to join our growing team. 🔹 Full-time, on-site role 🔹 Work on regulatory & non-regulatory studies 🔹 Hands-on LC-MS, peptides & oligonucleotide bioanalysis If you’re passionate about translational science and want to make an impact in drug discovery & development, we’d love to hear from you! 📩 Apply today: send your CV + short cover note to [email protected]
We’re thrilled to announce that our Business Development Manager, Janette Dalay Robertson , will be attending the Biomarkers & Precision Medicine Conference hosted by Oxford Global . Janette is looking forward to connecting with fellow attendees, exchanging insights and exploring new collaborations that can drive innovation in drug development and discovery. If you’ll be at the event, don’t miss the chance to meet Janette and chat about advancing precision medicine together. 📅 https://lnkd.in/eVAtT6hs
